These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26542479)

  • 1. Giant ribbon-like platelets mimicking microfilaria in a JAK2-positive myeloproliferative neoplasm.
    Sehgal T; Sharma P; Naseem S; Varma N
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):80-1. PubMed ID: 26542479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms.
    Koopmans SM; Schouten HC; van Marion AM
    Histol Histopathol; 2015 Feb; 30(2):151-61. PubMed ID: 25196073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms.
    Jaradat SA; Khasawneh R; Kamal N; Matalka I; Al-Bishtawi M; Al-Sweedan S; Ayesh MH
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):160-6. PubMed ID: 26256826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of JAK2 V617F mutant allele quantitation with clinical presentation and type of chronic myeloproliferative neoplasm.
    Malysz J; Crisan D
    Ann Clin Lab Sci; 2009; 39(4):345-50. PubMed ID: 19880761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent detection of the JAK2 V617F mutation in bone marrow core biopsy specimens from chronic myeloproliferative disorders using the TaqMan polymerase chain reaction single nucleotide polymorphism genotyping assay: a retrospective study with pathologic correlations.
    Bousquet M; Le Guellec S; Quelen C; Rigal-Huguet F; Delsol G; Brousset P
    Hum Pathol; 2006 Nov; 37(11):1458-64. PubMed ID: 16949922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis.
    De Stefano V; Fiorini A; Rossi E; Za T; Chiusolo P; Sica S; Leone G
    Hepatology; 2007 Mar; 45(3):831-2; author reply 832-3. PubMed ID: 17326212
    [No Abstract]   [Full Text] [Related]  

  • 8. A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 gene.
    Saba N; Safah H
    Blood; 2013 Aug; 122(6):861. PubMed ID: 24079014
    [No Abstract]   [Full Text] [Related]  

  • 9. MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms.
    Patnaik MM; Lasho TL; Finke CM; Gangat N; Caramazza D; Siragusa S; Hanson CA; Pardanani A; Tefferi A
    Leukemia; 2010 Apr; 24(4):859-60. PubMed ID: 20111067
    [No Abstract]   [Full Text] [Related]  

  • 10. Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.
    Guo BB; Allcock RJ; Mirzai B; Malherbe JA; Choudry FA; Frontini M; Chuah H; Liang J; Kavanagh SE; Howman R; Ouwehand WH; Fuller KA; Erber WN
    Am J Pathol; 2017 Jul; 187(7):1512-1522. PubMed ID: 28502479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.
    Holmström MO; Hjortsø MD; Ahmad SM; Met Ö; Martinenaite E; Riley C; Straten P; Svane IM; Hasselbalch HC; Andersen MH
    Leukemia; 2017 Feb; 31(2):495-498. PubMed ID: 27761006
    [No Abstract]   [Full Text] [Related]  

  • 12. The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow.
    Ingram W; Lea NC; Cervera J; Germing U; Fenaux P; Cassinat B; Kiladjian JJ; Varkonyi J; Antunovic P; Westwood NB; Arno MJ; Mohamedali A; Gaken J; Kontou T; Czepulkowski BH; Twine NA; Tamaska J; Csomer J; Benedek S; Gattermann N; Zipperer E; Giagounidis A; Garcia-Casado Z; Sanz G; Mufti GJ
    Leukemia; 2006 Jul; 20(7):1319-21. PubMed ID: 16617322
    [No Abstract]   [Full Text] [Related]  

  • 13. [High resolution melting analysis for detecting of JAK2V617F mutation in patients with myeloproliferative neoplasms].
    Chen HH; Yang JL; Lu HF; Zhou WJ; Yao F; Deng L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):112-6. PubMed ID: 24598662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive hepatomegaly and involvement by Janus Kinase 2-positive myeloproliferative neoplasm.
    Lennerz JK; Kuter DJ; Hasserjian R; Iafrate J
    Hepatology; 2010 Nov; 52(5):1855-6. PubMed ID: 20890944
    [No Abstract]   [Full Text] [Related]  

  • 15. Histological and molecular classification of chronic myeloproliferative disorders in the age of JAK2: persistence of old questions despite new answers.
    Hussein K; Bock O; Kreipe H
    Pathobiology; 2007; 74(2):72-80. PubMed ID: 17587878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2 and JMJD1C activate NFE2 in MPNs.
    Crispino JD
    Blood; 2018 May; 131(18):1998-1999. PubMed ID: 29724716
    [No Abstract]   [Full Text] [Related]  

  • 17. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCM1::JAK2 myeloproliferative neoplasm suggested by bone marrow histopathological features.
    Loscocco GG; Santi R
    Blood; 2024 Jun; 143(23):2439. PubMed ID: 38842862
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory detection of JAK2V617F in human myeloproliferative neoplasms.
    Kui JS; Espinal-Witter R; Wang YL
    Methods Mol Biol; 2013; 999():41-57. PubMed ID: 23666689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Bächli E; Gundelfinger M
    Praxis (Bern 1994); 2017 Jul; 106(15):807-813. PubMed ID: 28745110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.